All participants | Participants with CVDa | ||
---|---|---|---|
Males | Females | ||
Patients, n | 226 670 | 8588 | 7199 |
Median age, years (SD) | 46 (18) | 68 (13) | 71 (15) |
Median follow-up time, years (IQR) | 8.8 (5.5–8.8) | 8.8 (8.6–8.8) | 8.8 (8.4–8.8) |
Coronary heart disease, n (%) | 9487 (4) | 5695 (66) | 3792 (53) |
Heart failure, n (%) | 3290 (1) | 1466 (17) | 1824 (25) |
Stroke, n (%) | 3261 (1) | 1665 (19) | 1596 (22) |
Peripheral arterial disease, n (%) | 2846 (1) | 1499 (17) | 1347 (19) |
Asthma, n (%) | 20 734 (9) | 878 (10) | 1193 (17) |
Back/neck problems, n (%) | 26 136 (12) | 1741 (20) | 2132 (30) |
Cancer, n (%) | 16 237 (7) | 1772 (21) | 1582 (22) |
Congenital abnormalities of the central nervous system, n (%) | 138 (0) | 10 (0) | 3 (0) |
Colitis, n (%) | 1906 (1) | 95 (1) | 86 (1) |
Chronic obstructive pulmonary disease, n (%) | 8163 (4) | 1410 (16) | 1228 (17) |
Dementia, n (%) | 1313 (1) | 243 (3) | 326 (5) |
Depression, n (%) | 16 682 (7) | 712 (8) | 928 (13) |
Diabetes, n (%) | 15 187 (7) | 2395 (28) | 1887 (26) |
Epilepsy, n (%) | 1949 (1) | 180 (2) | 146 (2) |
Hearing, n (%) | 3525 (2) | 553 (6) | 466 (6) |
HIV/AIDS, n (%) | 332 (0) | 11 (0) | 2 (0) |
Intellectual disability, n (%) | 965 (0) | 37 (0) | 19 (0) |
Low vision, n (%) | 16 037 (7) | 2220 (26) | 2338 (32) |
Multiple sclerosis, n (%) | 494 (0) | 12 (0) | 20 (0) |
Osteoarthritis, n (%) | 15 553 (7) | 1419 (17) | 2278 (32) |
Osteoporosis, n (%) | 5759 (3) | 270 (3) | 1115 (15) |
Parkinson’s disease, n (%) | 694 (0) | 139 (2) | 94 (1) |
Rheumatoid arthritis, n (%) | 3077 (1) | 219 (3) | 358 (5) |
Schizophrenia, n (%) | 1021 (0) | 40 (0) | 28 (0) |
Tuberculosis, n (%) | 322 (0) | 21 (0) | 12 (0) |
↵a Heart failure, cerebrovascular accident, coronary heart disease, and/or peripheral arterial disease. CVD = cardiovascular disease. IQR = interquartile range. SD = standard deviation.